Skip to main content

Travel: Coronavirus

Question for Department of Health and Social Care

UIN 28108, tabled on 6 July 2021

To ask the Secretary of State for Health and Social Care, what steps his Department has taken to ensure that people who have been vaccinated against covid-19 with the AstraZeneca vaccine batches produced in India are able to travel to Europe under the digital covid certificate scheme.

Answered on

14 July 2021

The Government continues to engage with the European Union on certification to ensure that travel between the United Kingdom and the EU is supported by a common approach.

The Serum Institute of India (SII) manufactures Vaxzevria and Covishield and both branded vaccines are the same as the University of Oxford/AstraZeneca vaccine. All SII-made doses approved by the UK regulator, the Medicines and Healthcare products Regulatory Agency (MHRA) and administered in the UK were branded as the ’COVID-19 vaccine AstraZeneca’ which is now known commercially as ‘Vaxzevria’. The MHRA has not approved doses branded as ‘Covishield’ and none have been administered in the UK. All AstraZeneca vaccines given in the UK are the same product and appear on the NHS COVID Pass as Vaxzevria. The European Medicines Agency has authorised the Vaxzevria vaccine and it is therefore recognised by the EU.